Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer.
about
Yttrium-90 radioembolization of liver tumors: what do the images tell us?Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single CeTreatment response after radioembolisation in patients with hepatocellular carcinoma-An evaluation with dual energy computed-tomography.Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?Hepatic imaging following intra-arterial embolotherapy.Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.3D shape evolution of microparticles and 3D enabled applications using non-uniform UV flow lithography (NUFL).Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.Radioembolization treatment for liver metastases.Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.
P2860
Q26997064-16052F24-447B-4017-8940-BB292FA3A64CQ35570801-928E9059-2C12-4A2C-8F69-51602BC6CFC3Q37082835-1239E28E-EA67-40EE-8A82-F9D1AD3F2DF8Q37206772-64106400-47E5-4EB7-8E97-46D342438D6BQ37227541-096C8F72-0CFB-4828-9D52-0F96B65BCBE6Q37316201-2C047304-59B7-40F3-AB8D-02EF736B5603Q38716483-3226D0EE-7B03-423A-AC6B-F6836DBFA0D9Q38856938-A7791413-184C-4A23-81E8-FD23DE2B8022Q47620244-00F8908A-8B45-41B0-91F9-B78B23988C60Q48156557-80B49CCD-6F28-447C-954B-E95520630D09Q48285755-78CED791-6285-4ADD-8A51-C7761D7F1BAFQ49167503-198D087B-3360-4835-A1C5-0FA971A01E5EQ55283883-89D705A3-3416-4AD8-8570-FE57CAF23135Q55364224-DDCC1BFB-D44A-412B-8CA4-6A47EE1F3E29
P2860
Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Imaging characteristics follow ...... for unresectable liver cancer.
@en
Imaging characteristics follow ...... for unresectable liver cancer.
@nl
type
label
Imaging characteristics follow ...... for unresectable liver cancer.
@en
Imaging characteristics follow ...... for unresectable liver cancer.
@nl
prefLabel
Imaging characteristics follow ...... for unresectable liver cancer.
@en
Imaging characteristics follow ...... for unresectable liver cancer.
@nl
P2860
P1476
Imaging characteristics follow ...... for unresectable liver cancer.
@en
P2093
Lourens Bester
Shih-Chang Wang
P2860
P304
P356
10.1111/J.1754-9485.2011.02241.X
P577
2011-04-01T00:00:00Z